CompletedPhase 4

Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

United States47 participantsStarted 2019-08-05

Plain-language summary

In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males and females
✓. Age 18 years or greater
✓. Scheduled to undergo abdominal MRI with contrast at a performance site for evaluation of a hepatic lesion(s).

Exclusion criteria

✕. History of cardiac shunting
✕. History of acute cardiac ischemia
✕. History of hypersensitivity reaction to Lumason

What they're measuring

Accuracy of CEUS at Differentiating Focal Nodular Hyperplasia (FNH) From Hepatocellular Adenoma (HCA)

Timeframe: One day

Trial details

NCT IDNCT03652636

SponsorIndiana University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-21

Results submitted2024-06-15

View on ClinicalTrials.gov More Hepatic Disease trials